Our Services
Medical Information
Helpful Resources
Published on: 7/2/2026
Wondering if GLP-1 medications like semaglutide or tirzepatide are right for you? A structured 3-minute GLP-1 assessment reviews your personal and family medical history, current medications, gastrointestinal symptoms, and weight or diabetes management goals to help you evaluate suitability.
Positive indicators for GLP-1 therapy include:
Red flags that may point you toward alternatives include a personal history of pancreatitis or elevated risk of medullary thyroid cancer.
Understanding whether GLP-1 agonists fit your health profile is essential before speaking with your doctor. Taking a free, instant, online symptom check can help you clarify your symptoms, identify potential red flags, and prepare organized notes for your next medical visit—saving you time and giving you confidence in your next steps.
Reviewed for medical accuracy: 07/02/2026
If you've heard about GLP-1 agonists (such as semaglutide or liraglutide) for weight management or blood sugar control, you may be wondering if they're right for you. A quick, structured 3-minute GLP-1 symptom check can help you and your doctor decide on the next steps.
This guide explains:
GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medicines that can:
They can also cause side effects and aren't right for everyone. A quick GLP-1 symptom check helps you:
Set a timer for 3 minutes. As you go, jot down your answers. Be honest and concise.
Create a quick table or bullet list in your notes:
• Medical history highlights
• Key medications and supplements
• Gastrointestinal concerns
• Personal goals and commitment level
This snapshot will guide both you and your provider in determining if GLP-1 therapy is a safe, realistic option.
After your 3-minute GLP-1 symptom check, look for:
Positive indicators
• Type 2 diabetes with suboptimal control
• Obesity or overweight with related health issues
• No major GI disorders or pancreatitis history
• Willingness to learn injection technique and adjust diet
Potential red flags
• History of pancreatitis or severe gallbladder disease
• Medullary thyroid cancer in personal or family history
• Uncontrolled gastrointestinal problems
• Difficulty accessing regular follow-up care
If you see mostly positives and manageable concerns, a GLP-1 agonist could be a suitable next step. If red flags dominate, discuss alternative strategies with your healthcare provider.
Use a free online tool
For an extra layer of insight, try Ubie's Medically Approved LLM Symptom Checker Chat Bot to receive personalized guidance based on your symptoms and health concerns in just minutes.
Prepare for a healthcare visit
Talk to your doctor
Schedule an appointment with your primary care provider, endocrinologist, or obesity medicine specialist. Share your findings and discuss whether GLP-1 agonists align with your health needs.
Plan for monitoring
If you start GLP-1 therapy, you and your provider will want to track:
GLP-1 drugs are generally safe, but certain symptoms require prompt evaluation:
If you experience any of these, stop the medication and speak to a doctor right away.
A quick, 3-minute GLP-1 symptom check empowers you to take control of your health journey. By gathering key information in advance and using reputable tools—like the free Medically Approved LLM Symptom Checker Chat Bot—you'll arrive at your appointment ready to discuss tailored next steps.
Remember, no online check replaces a full medical evaluation. Speak to a doctor about anything that could be life-threatening or serious. With the right preparation and professional guidance, you can make an informed decision about whether GLP-1 therapy is right for you.
(References)
* Lingvay, I., & Raz, I. (2022). GLP-1 Receptor Agonists: A Journey From Mechanisms to Clinical Practice. *Diabetes Care*, *45*(Supplement 1), S8-S17.
* Nauck, M. A., & Quast, D. R. (2024). GLP-1 receptor agonists for the treatment of type 2 diabetes and obesity: mechanisms and clinical application. *Trends in Pharmacological Sciences*, *45*(3), 227-241.
* Drucker, D. J. (2023). GLP-1 receptor agonists: from discovery to clinical development. *Nature Reviews Drug Discovery*, *22*(8), 651-669.
* Davies, M. J., et al. (2024). AACE Consensus Statement: Comprehensive Management of Obesity with Pharmacotherapy and Metabolic Surgery. *Endocrine Practice*, *30*(4), 389-407.
* American Diabetes Association Professional Practice Committee. (2024). 9. Pharmacologic Approaches to Glycemic Treatment: *Standards of Care in Diabetes—2024*. *Diabetes Care*, *47*(Supplement 1), S158-S178.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.